Exatecan Intermediate 2

Exatecan Intermediate 2 (compound B) is a synthetic precursor to the camptothecin-derived anticancer agent Exatecan (DX-8951) . This topoisomerase I inhibitor is utilized in cancer research, with studies demonstrating its activity in both in vitro assays and in vivo models targeting ovarian, lung, and breast malignancies.